FDA Issues Early Alert for Abbott's TactiFlex Ablation Catheter Following Tip Detachment Reports
核心洞察
The FDA has issued an early alert regarding Abbott's TactiFlex Ablation Catheter (搜索) after three reported cases of catheter tips detaching and remaining in patients during procedures.
Abbott has received 29 total reports of damaged catheter tips, with most damage detected before device insertion, but has reported no serious injuries or deaths as of September 11.
The company has updated packaging instructions and modified tray design to prevent tip damage during catheter removal from packaging.
The Food and Drug Administration has issued an early alert regarding Abbott's TactiFlex Ablation Catheter (搜索), Sensor Enabled, following reports of catheter tip detachments that occurred in three patients during cardiac procedures. The alert, published Thursday as part of the FDA's Communications Pilot to Enhance the Medical Device Recall Program, addresses what officials classify as a potentially high-risk device issue.
Device Safety Concerns
Abbott has documented 29 reports of damaged catheter tips, with the majority detected before device insertion into patients. However, three recent cases involved tips that detached and remained in patients during procedures. According to Abbott, no further adverse outcomes were reported in these three patients, and as of September 11, the company has not received reports of serious injuries or deaths associated with this issue.
The safety concern stems from improper removal of the catheter from its packaging, which can result in tip damage. Abbott noted that the packaging design has remained unchanged since the device's international introduction in 2022, but the company has identified that users can inadvertently damage the catheter tip during the removal process.
Clinical Implications and Risks
The TactiFlex Ablation Catheter (搜索), Sensor Enabled is indicated for cardiac electrophysiological mapping and treatment of drug-refractory recurrent symptomatic paroxysmal atrial fibrillation (搜索) and concomitant atrial flutter (搜索). The device must be used in conjunction with a compatible RF generator and three-dimensional mapping system.
When tip detachment occurs during a procedure, patients face potential complications including embolism or migration of the detached material. Abbott warns that such events could lead to respiratory compromise, hemodynamic instability, stroke (搜索), ischemia (搜索), cardiac perforation (搜索), and vascular injury (搜索).
Abbott's Response and Updated Guidelines
On September 10, Abbott issued a letter to all affected customers with updated instructions for catheter removal. The company has implemented changes to the packaging tray design to reduce the likelihood of tip damage and has begun deploying the new packaging.
The updated guidance emphasizes several key steps for healthcare providers:
- Inspect packaging and catheter for damage or kinking before use
- Ensure the distal tip has been fully retracted from the tip protector before lifting it from the tray
- Carefully inspect electrodes and catheter tip for integrity and overall condition prior to use
- Replace the catheter if tip detachment is detected before insertion
Abbott has provided annotated photographs demonstrating proper removal techniques and requires customers to complete an acknowledgment form confirming they have received and understood the advisory notice.
Regulatory Oversight
The FDA continues to review information about this device issue and has committed to keeping the public informed as significant new information becomes available. The early alert system allows the agency to communicate potential risks while investigations are ongoing.
Healthcare providers experiencing adverse reactions, quality problems, or questions about the device can contact Abbott at 1-855-478-5833. The FDA encourages reporting of any problems through appropriate channels to support ongoing safety monitoring.